ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Euglucon 5®/Semi-Euglucon®:Roche Pharma (Schweiz) AG
Information professionnelle complèteDDDimprimé 
Forme gal./Grpe.th.Composit.PropriétésPharm.cinét.Indic./emploiPosolog./mode d'empl.PrécautionsEffets indésir.
Interact.SurdosageRemarquesNum. SwissmedicMise à jour 
A10BB01 - GlibenclamideATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A10 - Drugs Used in Diabetes
 
A10B - Blood Glucose Lowering Drugs, Excl. Insulins

Fixed combinations of blood glucose lowering drugs and lipid modifying agentes are classified here.

A10BB - Sulfonylureas
 

The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.
The DDD for gliclazide is based on the modified release formulation.

A10BB01 - Glibenclamide
Concentr.Adm.RouteNote
 Omicrocryst.substance
 O 
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home